KEEPING PEOPLE MOVING FOR 140 YEARS

For over 140 years, Algeos has been dedicated to “Keeping People Moving,” maintaining its deep-rooted family spirit since its inception in 1881 in Liverpool.

Today employing 70 people based in Speke and historically owned by only three families, including current owners, the Sheridan Family, the company is thriving internationally and domestically.

Alan Sheridan, Chairman of Algeos explains “‘Keeping People Moving’ is the inherent ethos which permeates our close-knit team and loyal customer base, shaping our identity as one of the UK’s leading manufacturers and distributors in the healthcare sectors of orthotics, prosthetics, podiatry, physiotherapy and comfort footwear”.

Algeos has been a member of the Liverpool Chamber since 1990 and the use of the Export service for documentation has been invaluable as export sales have grown.

As an innovator, Algeos collaborates with clinicians and industry experts to deliver cutting-edge products and technologies that significantly enhance patient care and achieve world-class service and sustainable standards.

Our brands are recognised globally and include Aortha, Diaped, Physioworx and Slimflex with exclusive 3rd party distribution rights of brands such as Darco, Interpod, Voxelcare and Poron which enabled us to distribute to 52 countries globally in the last year.

As market leader in the NHS we supply over 250 NHS trusts per annum, private practice clinics, private hospitals and elite sports clubs. We are a Northern Powerhouse Export Champion, and in 2024, we launched the Algeos Academy which is a pioneering initiative to provide best in class education and CPD to clinicians and technicians in addition to training on the products that we supply.

The dedication of our Liverpool based team is fundamental to our success. Renowned for our passion and expertise, we provide personalised support that sets us apart. This innate camaraderie and commitment to what we do are central to our continued prosperity and excellence. This was recognised in 2022, when we were awarded Investors in People Gold.

As we look ahead to 2025 and beyond, our commitment to ESG is embedded into our core strategic vision. In 2024, Algeos achieved ISO 14001 and we are aiming to achieve Net Zero emissions by 2030. These goals reflect our leadership’s dedication to not just adhering to current environmental standards but setting new benchmarks within the orthotic therapy industry and for organisations of our size. Algeos are committed to keeping people moving whilst creating sustainable footprints for the future.